Video
Eye on Oversight: Exclusions
January 18, 2017
The HHS OIG has authority to exclude, or ban, individuals and entities from participation in Federal health care programs. Employers must check that they are not employing an excluded individual because they may face a financial penalty. This video also covers OIG's exclusions database, and possible reinstatement.
Eye on Oversight:
2016 Year in Review
December 14, 2016
This month's Eye on Oversight recaps OIG's work in 2016, including topics like the launch of Healthcare.gov, child care safety lapses and the largest healthcare fraud takedown in history.
Eye on Oversight:
Challenges in Indian Health Service Hospitals
November 15, 2016
This month's Eye on Oversight focuses on Indian Health Service (IHS) hospitals. IHS provides health care services for approximately 2.2 million American Indians and Alaska Natives. OIG examined 28 IHS-operated hospitals, to look at how it monitors quality oversight and ensures that facilities meet federal standards.
Eye on Oversight:
Vulnerabilities in Personal Care Services
October 18, 2016
This month's Eye on Oversight highlights vulnerabilities in Medicaid's Personal Care Services (PCS) program. Investigations have revealed abuse and neglect by PCS attendants. OIG hopes that its recommendations to the Centers for Medicare and Medicaid Services will ensure that people in need of PCS services are not at risk of abuse or neglect.
OIG-HHS Testifies on OIG's Oversight of the Affordable Care Act
September 26, 2016
Gloria Jarmon, Deputy Inspector General for Audit Services, Office of Inspector General, U.S. Department of Health and Human Services, testifies before the House Committee on Energy and Commerce: Subcommittee on Oversight and Investigations and Subcommittee on Health: "The Affordable Care Act on Shaky Ground: Outlook and Oversight"
Eye on Oversight:
Provider Self-Disclosure Protocol
September 19, 2016
This month's Eye on Oversight focuses on OIG's Provider Self-Disclosure Protocol. If health care providers find evidence of potential fraud in Federal health care programs, they can voluntarily report it to the OIG. This video features the largest self-disclosure case in history.
Bloomberg BNA Interviews OIG Assistant Inspector General and Chief Data Officer
June 28, 2016
OIG Assistant Inspector General and Chief Data Officer Caryl Brzymialkiewicz talks with Bloomberg BNA about the OIG's growing use of data collection analytics in investigations and audits.
Eye on Oversight:
Home Health Fraud
June 20, 2016
Medicare's home health benefit provides care for patients who have an illness or injury. It's usually cheaper, and more convenient, than going to a hospital or skilled nursing facility. Although it's an important service, people are scamming the home health care program.
HHS-OIG Testifies on Medicare and Medicaid: Combatting Improper Payments and Ineligible Providers
May 26, 2016
Ann Maxwell, Assistant Inspector General, Office of Inspector General, U.S. Department of Health and Human Services, testifies before the House Committee on Energy and Commerce: Subcommittee on Oversight and Investigations: "Medicare and Medicaid Program Integrity: Combatting Improper Payments and Ineligible Providers"
Bloomberg BNA Interviews OIG Principal Deputy Inspector General
May 26, 2016
OIG Principal Deputy Inspector General, Joanne Chiedi, talks about data analysis, budget resources and prescription drug abuse
Daniel R. Levinson's Keynote Address at the 2016 HCCA Compliance Institute
May 16, 2016
Daniel R. Levinson, Inspector General, Office of Inspector General, U.S. Department of Health and Human Services, gives the keynote address at the 20th annual HCCA Compliance Institute on April 18th, 2016.
Eye on Oversight:
Kickbacks to Physicians
May 11, 2016
Kickbacks in health care are a big problem. They can lead to higher costs for patients, unnecessary tests, and doctors making decisions based on making money, versus caring for patients.
Eye on Oversight:
Dangerous Drugs – Opioids
April 11, 2016
The number of people in the U.S. who die from opioid overdoses is on the rise. These drugs include Vicodin, Percocet, and OxyContin. Medicare is paying for an increasing number of opioids, and other prescription drugs, that when used improperly, can have devastating effects.
HHS-OIG Testifies on HealthCare.gov:
A Review of Operations and Enrollment
March 23, 2016
Erin Bliss, Assistant Inspector General, Office of Inspector General, U.S. Department of Health and Human Services, testifies before the Senate Finance Committee: "HealthCare.gov: A Review of Operations and Enrollment"
Eye on Oversight:
Child Care Safety Lapses
March 7, 2016
OIG found major health and safety violations at many state-licensed day care providers around the country. States should meet new legal requirements to fix these lapses.
HHS OIG testifies on the Federal Medical Assistance Percentage
February 18, 2016
John Hagg, Director of Medicaid Audits, Office of Audit Services, Office of Inspector General, U.S. Department of Health and Human Services, testifies before the House Committee on Energy and Commerce Subcommittee on Health. The hearing focused on Medicaid and CHIP's Federal Medical Assistance Percentage.
Eye on Oversight: Medicare Part D Fraud
January 11, 2016
Fraud and abuse in Medicare Part D is going up. Part D helps millions of beneficiaries pay for prescription drugs, but billing schemes and drug diversion are causing major financial and social problems.
Let's start by choosing a topic
